Immunomedics Receives Complete Response Letter From FDA for Sacituzumab Govitecan Biologics License Application
pharmaceutical investing scPharmaceuticals Receives Complete Response Letter from the FDA for FUROSCIX
Oreterra Announces Closing of $9.3 Million First Tranche of Oversubscribed and Upsized $9.7 Million Non-Brokered Private Placement, Second Tranche to Close March 4
